Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2005
11/24/2005CA2565514A1 3-(((4-phenyl)-piperazine-1-yl)-alkyl)-3-alkyl-1, 3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
11/24/2005CA2565424A1 Macromolecule-containing sustained release intraocular implants and related methods
11/24/2005CA2565421A1 Synergism of gos and polyfructose
11/24/2005CA2565407A1 Compounds for enzyme inhibition
11/24/2005CA2565249A1 Intravitreal implants in conjunction with photodynamic therapy to improve vision
11/24/2005CA2565247A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
11/24/2005CA2565243A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2565211A1 Amino-tetrazoles analogues and methods of use
11/24/2005CA2565189A1 Cis-2,4,5-triphenyl imidazolines and their use as anti-cancer medicaments
11/24/2005CA2565186A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
11/24/2005CA2565154A1 Compositions for affecting weight loss
11/24/2005CA2565067A1 Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision
11/24/2005CA2565051A1 Novel use of peptide compounds for treating dyskinesia
11/24/2005CA2565026A1 Novel sustained-action bronchodilating agents for use in the treatment of respiratory diseases
11/24/2005CA2564952A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
11/24/2005CA2564948A1 An estradiol derivative or an estratopone derivative containing sustained release intraocular implant as well as related methods of manufacturing
11/24/2005CA2564751A1 Neuropeptide receptor modulators
11/24/2005CA2564517A1 1-aryl-4-substituted isoquinolines
11/24/2005CA2564489A1 Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
11/24/2005CA2564379A1 Aerosol formulation for inhalation of beta agonists
11/24/2005CA2564325A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/24/2005CA2564319A1 Topical regulation of triglyceride metabolism
11/24/2005CA2564207A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments
11/24/2005CA2564199A1 Pyrimidine derivatives for the treatment of abnormal cell growth
11/24/2005CA2564158A1 Cationic dyes and dyestuff for keratin fibres containing said compounds
11/24/2005CA2564027A1 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones
11/24/2005CA2563793A1 Polymorphic forms of nateglinide
11/24/2005CA2563704A1 Methods and compositions for treatment of preeclampsia
11/24/2005CA2563607A1 4,5-disubstituted-2-aryl pyrimidines
11/24/2005CA2563601A1 Combinations of substituted 1-phenyl-1,5-dihydro-pyrido- [3,2-b] indol-2-ones and other hiv inhibitors
11/24/2005CA2563489A1 Topical methadone compositions and methods for using the same
11/24/2005CA2563305A1 Combination therapies for cancer and proliferative angiopathies
11/24/2005CA2563207A1 Use of selective cytokine inhibitory drugs in myelodysplastic syndromes
11/24/2005CA2562948A1 Enhanced biologically active conjugates
11/24/2005CA2562857A1 Novel imidazole derivatives, the production thereof, and the use of the same as intermediate products for producing medicaments and pesticides
11/24/2005CA2562715A1 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes
11/24/2005CA2562714A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs
11/24/2005CA2562597A1 Preparation of candesartan cilexetil in high purity
11/24/2005CA2562283A1 Methods, compositions, and preparations for delivery of immune response modifiers
11/24/2005CA2561859A1 Beta-carbolines useful for treating inflammatory disease
11/24/2005CA2561717A1 Combination of organic compounds
11/24/2005CA2561525A1 Aryl sulfones and uses related thereto
11/24/2005CA2560981A1 Polymer-based sustained release device
11/24/2005CA2560108A1 Immunostimulatory nucleic acids for inducing il-10 responses
11/24/2005CA2508065A1 Antiproliferative drug and delivery device
11/24/2005CA2507712A1 Pharmaceutical compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1598422A2 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
11/23/2005EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases
11/23/2005EP1598371A1 Medicinal composition for ophthal use containing acetylated hyaluronic acid
11/23/2005EP1598355A1 Therapeutic agent for schizophrenia
11/23/2005EP1598354A1 Compounds containing a N-heteroaryl moiety linked to fused ring moieties for the inhibition of NAD(P)H oxidases and platelet activation
11/23/2005EP1598352A1 1-Glyoxylamide indolizines for treating cancer
11/23/2005EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
11/23/2005EP1598347A1 Polymorphs of pantoprazole sodium salt and process for the preparation thereof
11/23/2005EP1598346A1 Process for producing acid adduct salt of polyacidic base compound
11/23/2005EP1598345A1 Benzopyran compounds, process for preparing the same and their use
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598337A1 Method of obtaining an antiepileptic agent
11/23/2005EP1598334A1 Thyroid hormone analogues and methods for their preparation
11/23/2005EP1598333A1 Process for the preparation of (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane, acid addition salts thereof and its use for the synthesis of ivabradine and for its pharmaceutically acceptable acid addition salts
11/23/2005EP1598083A1 Disinfecting composition comprising at least one peroxycarboxylic acid derivative and its use for disinfection of a room or air
11/23/2005EP1598081A2 Conjugates of a water-soluble amino acid polymer and a drug
11/23/2005EP1598079A1 Remedies for allergic contact dermatitis
11/23/2005EP1598074A1 Stabilized preparation containing protein
11/23/2005EP1598070A1 Administration of enoxaparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction
11/23/2005EP1598069A2 Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
11/23/2005EP1598068A1 Antipsychotic heterocycle compounds
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1598066A1 Powder inhalant of sumatriptan and the method of preparation thereof
11/23/2005EP1598065A2 Drugs for improving prognosis of brain injury
11/23/2005EP1598064A1 Combination of alkane diol and hydroxy acid for the treatment of acne
11/23/2005EP1598063A1 Synergic compositions comprising vitamins, minerals and trace elements to stimulate removal of intracellular lipids
11/23/2005EP1598059A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/23/2005EP1598057A1 Combination of acid protease enzymes and acidic buffers and uses thereof
11/23/2005EP1598054A2 Method of suppressing appetite
11/23/2005EP1598045A2 Stable water-in-oil emulsion system
11/23/2005EP1597978A1 Synergism of GOS and polyfructose
11/23/2005EP1597585A2 Method for selecting a candidate drug compound
11/23/2005EP1597398A1 Tailored treatment suitable for different forms of mastocytosis
11/23/2005EP1597385A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1)
11/23/2005EP1597365A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatment of cancer
11/23/2005EP1597357A1 Compositions and processes using sirna, amphipathic compounds and polycations
11/23/2005EP1597354A2 System for external control of oncolytic virus replication
11/23/2005EP1597350A2 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection
11/23/2005EP1597349A2 Methods of screening for trpm5 modulators
11/23/2005EP1597302A1 Polymer guanidine derivatives as a cytostatic medicament
11/23/2005EP1597260A1 Triazole compounds useful in therapy
11/23/2005EP1597259A1 Nitrogen-substituted hexahydropyrazino 1,2-a]pyrimidine-4,7-dione derivatives, method for the production and use thereof as medicaments
11/23/2005EP1597257A1 Oxazole-derivatives as ppar agonists
11/23/2005EP1597256A1 N-heterocyclyl-substituted amino-thiazole derivatives as protein kinase inhibitors
11/23/2005EP1597255A1 Rhodanine derivatives and pharmaceutical compositions containing them
11/23/2005EP1597253A2 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
11/23/2005EP1597249A1 Anthelmintic agents and insecticidal compositions
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/23/2005EP1597242A1 Hiv inhibiting 1,2,4-triazines
1 ... 4459 4460 4461 4462 4463 4464 4465 4466 4467 4468 4469 4470 4471 4472 4473 4474 4475 4476 4477 4478 4479 ... 7860